Chambers & Partners recognises Arbor Law for its distinctive “Big Law without the baggage” model.
Arbor Law has been recognised in the Chambers UK 2025 Guide for its outstanding work supporting small and medium-sized enterprises (SMEs) across the UK – a testament to the firm’s innovative, senior-only model that combines City-firm expertise with in-house commercial insight, designed to eliminate inefficiency and make excellence more accessible to small and mid-sized businesses seeking legal support.
Regulation of Clinical Trials in the Republic of Kazakhstan
What is a clinical trial? A clinical trial (“CT”) is a study involving human subjects, conducted to identify or confirm the safety and effectiveness of means, methods, and technologies for the prevention, diagnosis, and treatment of diseases. What types of CTs are there? A non-interventional CT is a study which is conducted after the state …
Continue reading “Regulation of Clinical Trials in the Republic of Kazakhstan”
Commerce Legislation News Uzbekistan – November 2025 The regulatory framework governing trade activities in the Republic of Uzbekistan (hereinafter referred to as “Uzbekistan”) has undergone significant amendments designed to strengthen consumer protection mechanisms. Below is an overview of the key developments. The Government has approved new regulations governing promotional campaigns and discounts in retail trade. …
Gernandt & Danielsson advises Worldline in connection with the contemplated divestment of its payment orchestration platform PaymentIQ
Gernandt & Danielsson advises Worldline, a European leader in payment services, in connection with the divestment of PaymentIQ, a payment orchestration platform, to Incore Invest for an estimated cash proceeds at closing of c. EUR 160 million, after excess cash distribution.
Argus Partners Advises Ripplr on its USD 45 million Series C fundraise
Argus Partners is pleased to announce that it has advised Intelligent Retail Private Limited (“Ripplr”), a technology driven distribution and supply chain platform, in connection with its Series C fundraise. The funding round, comprising a mix of primary and secondary transactions, along with debt, witnessed participation from new investor State Bank of India, as well …
Continue reading “Argus Partners Advises Ripplr on its USD 45 million Series C fundraise”
Homburger advises EQT on the sale of an additional 10% in Galderma to L’Oréal, reinforcing L’Oréal’s strategic investment in Galderma
On December 8, 2025, EQT announced the sale of an additional 10% stake in Galderma Group AG (SIX: GALD) by a consortium led by EQT, which includes Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as sellers) to L’Oréal S.A. for an undisclosed amount. Following the transaction, …
BUREN expands with Valegis Advocaten
The Hague, 9 December 2025 – As of 1 January 2026, BUREN Legal Tax Notary welcomes Valegis Advocaten to their firm. This step further expands BUREN’s legal services and strengthens its capacity to support clients effectively.
Bär & Karrer Advises logol on Strategic Investment by Campari Group’s Controlling Shareholder Lagfin
The controlling shareholder of Campari Group, Luxembourg-based Lagfin S.C.A., completed through its Swiss branch a strategic investment in logol AG, a Swiss leader in AI and digital transformation focused on AI-driven, mission-critical SaaS solutions for professional services. Lagfin’s equity investment marks a significant milestone for logol, providing funds to accelerate the development of EFFE Premium, …
EY Tax Law strengthens its operations with new hires in El Salvador
EY strengthens its Tax & Law practice with the addition of eight attorneys, including two new Associate Partners from the firm GarciaBodan. San Salvador, November 27, 2025. Under the leadership of Antonio Ruiz, EY Tax & Law Leader for Central America, Panama, and the Dominican Republic, EY is strengthening its presence in El Salvador with …
Continue reading “EY Tax Law strengthens its operations with new hires in El Salvador”
Lakshmikumaran & Sridharan advises Sai Parenteral’s Limited and its Singapore subsidiary in the cross-border acquisition of Noumed Pharmaceuticals Pty Ltd
New Delhi, December 06, 2025: Lakshmikumaran & Sridharan Attorneys advised and acted for Sai Parenteral’s Limited and its Singapore subsidiary, Sai Parenterals Pte Limited in their cross-border acquisition of 74.6% equity stake in Noumed Pharmaceuticals Pty Ltd (Australia) through a combination of secondary purchase from Noumed Life Sciences Limited (United Kingdom) along with primary subscription …